Lenizak 75 mg FC tablet.

Lenizak 75 mg FC tablet.

S5
PDF Leaflet Revision Date: 26 September 2025


Clinical Summary

Quick overview from the medicine insert

Indication

Short-term treatment of moderate to severe acute pain.

Dosage (summary)

1 tablet every 8 hours, max 3 tablets/day for adults; max 2 tablets/day for elderly.

Onset of Action / Duration

Onset: 30 mins, Duration: 6-8 hours

Special Populations

  • Elderly
  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Key Drug Interactions

  • Other NSAIDs
  • Anticoagulants
  • MAO inhibitors
  • CNS depressants

Contraindications

  • Hypersensitivity to components
  • Severe hepatic impairment
  • Moderate to severe renal impairment
  • Active gastrointestinal bleeding

Common side effects

  • Nausea
  • Dizziness
  • Constipation
  • Vomiting

Counselling Points

  • Take with water 30 mins before meals.
  • Do not exceed recommended dose.
  • Report any signs of gastrointestinal bleeding.

Serious warnings

  • Risk of gastrointestinal bleeding
  • Potential for respiratory depression
  • Risk of addiction and dependence

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Lenizak 75 mg FC tablet.
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW